| 慢性淋巴细胞白血病最新研究进展:第13届卢加诺国际淋巴瘤大会报道 |
| |
| 引用本文： | 赵东陆,马军. 慢性淋巴细胞白血病最新研究进展:第13届卢加诺国际淋巴瘤大会报道[J]. 白血病．淋巴瘤, 2015, 0(9). DOI: 10.3760/cma.j.issn.1009-9921.2015.09.001 |
| |
| 作者姓名： | 赵东陆 马军 |
| |
| 作者单位： | 150010,哈尔滨血液病肿瘤研究所 |
| |
| 摘 要： | 第13届国际淋巴瘤大会(ICML)于2015年6月17日至20日在瑞士卢加诺召开.由于近几年慢性淋巴细胞白血病治疗研究方面获得了较大进展,尤其是2014年,美国及欧洲批准了4种治疗慢性淋巴细胞白血病的新药,因此关于慢性淋巴细胞白血病的议题备受关注.文章就第13届ICML报告的慢性淋巴细胞白血病的最近进展进行介绍.
|
| 关 键 词： | 白血病,淋巴细胞,慢性 新药 国际淋巴瘤大会 |
The latest progress of chronic lymphocytic leukemia: reports from the 13th International Conference on Malignant Lymphoma,Lugano |
| |
| Abstract: | The 13th International Conference on Malignant Lymphoma (ICMC) was held in Lugano, Switzerland from June 17 to 20, 2015.There was the enormous progress in the treatment of chronic lymphocytic leukemia in the past years, especially in 2014, 4 new agents for the treatment of chronic lymphocytic leukemia were approved in USA and Europe, which caused great attention on the issue of chronic lymphocytic leukemia.The latest progress of chronic lymphocytic leukemia reported at the conference was briefly introduced in this paper. |
| |
| Keywords: | Leukemia,lymphocytic,chronic New agent International Conference on Malignant lymphoma |
| 本文献已被 万方数据 等数据库收录！ |
|
